For Residents

Oculocutaneous Albinism

Dr. Consuelo V. David describes the eureka moment residents experience when a patient presents with a condition they have studied but have never seen in practice. She relates it to her understanding of albinism as a medical student following a rotation in Lilongwe, Malawi. Dr. David provides an overview of oculocutaneous albinism, reviewing each type and the clinical implications. She also describes albino awareness initiatives in sub-Saharan Africa and offers resources that are available for patients. This information is relevant for US physicians who also are bound to care for patients with albinism, with the message that with any genetic condition, a patient's quality of life can be remarkably improved with proper support and education.


 

Recommended Reading

Technique is key for filler injection in darker skin
MDedge Dermatology
What Is Your Diagnosis? Argyria
MDedge Dermatology
Vitiligo Patients Seeking Depigmentation Therapy: A Case Report and Guidelines for Psychological Screening
MDedge Dermatology
Pigmented Bowen Disease in a Black Patient: Novel Dermoscopic Findings [letter]
MDedge Dermatology
Skin-Lightening Agents: An Overview of Prescription, Office-Dispensed, and Over-the-counter Products
MDedge Dermatology
Chemical Leukoderma Induced by Amyl Nitrite
MDedge Dermatology
Minocycline-Induced Hyperpigmentation Involving the Oral Mucosa After Short-term Minocycline Use
MDedge Dermatology
Treating Acne Scars in Patients With Fitzpatrick Skin Types IV to VI Using the 1450-nm Diode Laser
MDedge Dermatology
PDL Versus PDT for Port-wine Stains
MDedge Dermatology
Safety First: Fractional Nonablative Laser Resurfacing in Fitzpatrick Skin Types IV to VI
MDedge Dermatology